Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
29.39
+0.88 (+3.09%)
Streaming Delayed Price
Updated: 11:41 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
August 03, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
July 13, 2023
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.
Via
InvestorPlace
7 Biotech Stocks to Sell in July
July 13, 2023
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Via
InvestorPlace
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval.
Via
Benzinga
Why Cassava Sciences Stock Is Trading Down Today
July 05, 2023
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower Wednesday.
Via
Benzinga
Why Shares of Cassava Sciences Are Dropping Wednesday
July 05, 2023
The company announced phase 3 trial results for its lead Alzheimer's therapy.
Via
The Motley Fool
Why Shares of Cassava Sciences Jumped This Week
May 12, 2023
Cassava Sciences finished dosing in one of its phase 3 trials for its Alzheimer's therapy Simufilam.
Via
The Motley Fool
Stock Market Round-Up: Rivian Rides High, Meta Platforms Makes Moves, And Tesla Ticks Up
July 05, 2023
Via
Benzinga
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
July 05, 2023
Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its Phase 3 clinical trials for its Alzheimer's treatment.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 05, 2023
Via
Benzinga
Dow, S&P 500 Move Lower On Renewed Fed Fatigue
July 05, 2023
Stocks are moving lower ahead of the Federal Reserve's June meeting minutes, which are due out this afternoon.
Via
Talk Markets
Promising Alzheimer's Treatment: Cassava Sciences' Simufilam Slows Cognitive Decline by 38% in Clinical Study
July 05, 2023
Cassava Sciences Inc (NASDAQ: SAVA) announced topline clinical results from its Cognition Maintenance Study (CMS), a small proof-of-concept study designed to demonstrate the effects of simufilam versus...
Via
Benzinga
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
May 09, 2023
Today, shareholders in Cassava Sciences and SAVA stock are cheering some positive research data for its key drug candidate.
Via
InvestorPlace
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 05, 2023
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...
Via
Benzinga
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease
July 05, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
New Research Shows Simufilam Suppresses Overactive mTOR
June 27, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
New Publication Highlights Basic Science Supporting Simufilam
June 12, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
June 01, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
May 21, 2023
These seven high-risk stocks could ultimately rocket to the moon, or fall to the depths of the stock market graveyard.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2023
Via
Benzinga
Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease
May 11, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
May 08, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
May 01, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
April 26, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Short Interest Sector Focus: Healthcare Sector
April 04, 2023
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Why Is Asana (ASAN) Stock Up 24% Today?
March 09, 2023
Asana (ASAN) stock is on the rise Thursday as investors react to the CEO share purchase plans and its latest earnings report.
Via
InvestorPlace
ETSY Stock Falls on Double Downgrade
March 09, 2023
Etsy (ETSY) stock is falling on Thursday after the e-commerce company's shares were hit with a double downgrade from Jefferies.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.